IP Valuation

US drug maker Abbott Laboratories has agreed to pay-$3.7 billion or Rs 17,000 crore-to buy the domestic formulations business of Piramal Healthcare in a scramble among global pharmaceutical companies to get a foothold in a promising market. Abbott, which is celebrating its 100th year in India and owns such brands as Creamffin, Brufen and [...]